KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Debt Ratio (2016 - 2020)

Nektar Therapeutics (NKTR) has 10 years of Debt Ratio data on record, last reported at 0.27 in Q1 2020.

  • For Q1 2020, Debt Ratio rose 136.08% year-over-year to 0.27; the TTM value through Mar 2020 reached 0.27, up 136.08%, while the annual FY2019 figure was 0.25, 121.44% up from the prior year.
  • Debt Ratio reached 0.27 in Q1 2020 per NKTR's latest filing, up from 0.25 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.57 in Q3 2016 and bottomed at 0.11 in Q2 2018.
  • Average Debt Ratio over 5 years is 0.33, with a median of 0.42 recorded in 2017.
  • Peak YoY movement for Debt Ratio: crashed 79.28% in 2018, then soared 136.08% in 2020.
  • A 5-year view of Debt Ratio shows it stood at 0.43 in 2016, then increased by 12.59% to 0.48 in 2017, then crashed by 76.17% to 0.11 in 2018, then skyrocketed by 121.44% to 0.25 in 2019, then rose by 6.0% to 0.27 in 2020.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.27 in Q1 2020, 0.25 in Q4 2019, and 0.12 in Q3 2019.